Você procurou por: barr (Inglês - Dinamarquês )

epstein-barr
(herunder

barr chromatin body
kønskromatin

barr nucleus analysis
barr's kerneanalyse

epstein-barr nuclear antigen
epstein-barr's nukleærantigen

epstein-barr; mononucleosis infectiosa
mononukleose

mononucleosis, infectious; epstein-barr
mononukleose

legal aspects of financial issues nicola barr
juridiske aspekter af finansielle anliggender nicola barr

epstein-barr virus-associated lymphoproliferative disorders
epstein-barr virus-associerede lymfoproliferative sygdomme

ebv (epstein-barr virus) lymphoproliferative disease
ebv (epstein-barr virus) lymfoproliferativ sygdom

corporate responsibility policy felismino alcarpe ba r b 1 right financial issues nicola barr
politik for virksomhedsansvar felismino alcarpe

recombinant glycoprotein gp350 of epstein-barr virus (henogen 350)
recombinant glycoprotein gp350 of epstein- barr virus (henogen 350)

barr. to a specification approved in accordance with the procedure laid down in article 18.2.
barr. i overensstemmelse med en specifikation, der er godkendt efter proceduren i artikel 18, stk. 2.

denmark was recognised as a protected zone with respect to cryphonectria parasitica (murrill) barr.
danmark blev anerkendt som beskyttet zone med hensyn til cryphonectria parasitica (murrill) barr.

nulojix must not be used in patients who have not been exposed to the epstein-barr virus or in whom previous exposure is uncertain.
nulojix må ikke anvendes til patienter, der ikke har været eksponeret for epstein-barr-virus, eller hvis tidligere eksponering for denne virus er usikker.

greece has submitted information showing that cryphonectria parasitica (murrill) barr is now established in those regions.
grækenland har forelagt dokumentation for, at cryphonectria parasitica (murrill) barr nu er etableret i de pågældende områder.

in greece, crete and lesvos were recognised as protected zones with respect to cryphonectria parasitica (murrill) barr.
i grækenland er kreta og lesvos blevet anerkendt som beskyttede zoner med hensyn til cryphonectria parasitica (murrill) barr.

a variety of innovations, such as techniques for early detection of epstein-barr (ebv) and cmv infections, bone marrow augmentation, the adjunct use of the interleukin-2 antagonist daclizumab, lower initial tacrolimus doses with target trough levels of 10 to 15 ng/ ml, and most recently allograft irradiation were considered to have contributed to improved results in this indication over time (abu- elmagd et al., ann surg 2001; 234:404).
forskellige innovationer som teknik til tidlig diagnose af epstein- bar (ebv) og cmv infektioner, knoglemarvs forøgelse, samtidig brug af interleukin- 2 antagonisten daclizumab, lavere initiale doser af tacrolimus med dalkoncentrationer på 10- 15 ng/ ml og senest allotransplantat bestråling, har bidraget til at forbedre resultaterne ved denne indikation (abu- elmagd et al., ann surg 2001; 234: 404).